Compare PEPG & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | CCRN |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 270.9M |
| IPO Year | 2022 | 2001 |
| Metric | PEPG | CCRN |
|---|---|---|
| Price | $5.76 | $9.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $11.67 | ★ $13.15 |
| AVG Volume (30 Days) | ★ 721.3K | 478.3K |
| Earning Date | 06-08-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $816,484,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.89 | $7.43 |
| 52 Week High | $7.80 | $16.19 |
| Indicator | PEPG | CCRN |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 69.62 |
| Support Level | $4.36 | $7.68 |
| Resistance Level | $6.81 | $14.23 |
| Average True Range (ATR) | 0.59 | 0.41 |
| MACD | -0.07 | 0.15 |
| Stochastic Oscillator | 35.87 | 82.50 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.